Achiko Logo cropped.jpg
Market Outlook and Production Plan Update for AptameX
20 oct. 2021 07h30 HE | Achiko AG
After receiving product and registration approval from Indonesia’s Ministry of Health in August, Achiko is positioned to produce up to a million AptameX test kits in Q4 2021, and more if the supply...
Achiko Logo cropped.jpg
Achiko’s Rapid Covid-19 Diagnostic Test AptameX™ Receives Product and Registration Approval from Indonesia’s Ministry of Health
25 août 2021 07h30 HE | Achiko AG
AptameX™, Achiko’s breakthrough DNA aptamer-based diagnostic test for Covid-19, received product and registration emergency use approval from the Ministry of Health in Indonesia, alongside its sister...
Achiko Logo cropped.jpg
Achiko Engages EpiMetrics to Expand Covid-19 Testing Operations with Udayana University in Bali, Indonesia in the Implementation of a Mass Testing Program
15 juil. 2021 07h30 HE | Achiko AG
ZURICH, Switzerland, July 15, 2021 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SWX:ACHI, ISIN CH0522213468) (“Achiko”, the “Company”), a global healthtech company...
Achiko Logo cropped.jpg
Achiko Announces an Extension of its Convertible Loan Transaction with Negma Group
18 juin 2021 12h01 HE | Achiko AG
ZURICH, June 18, 2021 (GLOBE NEWSWIRE) -- Achiko AG (SWX:ACHI, ISIN CH0522213468) (“Achiko”, the “Company”) has successfully extended the subordinated convertible loan agreement of CHF 900,000 dated...
Achiko Logo cropped.jpg
Achiko AG Announces Successful Integration of its Teman Sehat Digital Ecosystem and AptameX Covid-19 Diagnostic Testing Platform for Launch in Indonesia
03 juin 2021 00h45 HE | Achiko AG
Wireless Integration of AptameX Covid-19 Test with Teman Sehat CompletedTeman Sehat’s Open API Allows for Integration of Third Party Testing PlatformsTeman Sehat Provides Results within 15 minutes,...